SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ergobilt (ERGB) - Ergonomic Chairs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Patterson who wrote (687)2/8/1998 11:10:00 PM
From: Scott D. Hakala  Read Replies (1) of 900
 
Jim, The Chairman of ERGb basically said the same thing in a message on my business phone the other day. Gerald said that the business was going well but the stock market "stinks". The market is being driven by traders that haven't done their homework or that are interested in manipulating a microcap stock. The key is for ERGB to convince buyers to come back in and realize that the earnings forecasts for 1998 are still holding. Otherwise the stock will still be vulnerable to short attacks. For example, two of my former colleagues told me that they recently ran their numbers looking for potentially underpriced stocks and found ERGB to be severely undervalued. They both bought shares feeling that the Company is a steal at this time. I talked with a broker the other day who said the same thing.

If one researches ERGB, then one will find that product sales are up and the Company is improving gross margins.

I think that your analysis of the bad earnings reportkilling the stock is more than a bit off. The stock has been punished by rumors and, despite that, I do know that the Company is producing positive earnings. At the current pricing, ERGB is a steal given its long-term earnings growth and earnings projections.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext